| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HUMANIGEN, INC | Chief Medical Officer | Stock Option (Right to Buy) | 537,164 | $2,433,353 | $4.53 | 27 Jul 2022 | Direct |
| Celularity Inc | Chief Medical Officer | Class A Common Stock | 1,122,238 | $487,051 | $0.4340 | 17 Feb 2024 | Direct |
| Celularity Inc | Chief Medical Officer | Stock Option Grant (Right to Buy) | 205,213 | 16 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CELU | Celularity Inc | 16 Feb 2024 | 2 | -$22,899 | 4 | Chief Medical Officer | 21 Feb 2024, 21:38 |
| CELU | Celularity Inc | 14 Jul 2023 | 1 | $0 | 4 | Chief Medical Officer | 19 Jul 2023, 12:21 |
| CELU | Celularity Inc | 17 Feb 2023 | 1 | $0 | 4 | Chief Medical Officer | 22 Feb 2023, 20:18 |
| CELU | Celularity Inc | 03 Oct 2022 | 1 | $0 | 4 | Executive Vice President, Chief Medical Officer | 04 Oct 2022, 16:10 |
| CELU | Celularity Inc | 29 Sep 2022 | 0 | $0 | 3 | Executive Vice President, Chief Medical Officer Exhibit 24 - Power of Attorney | 04 Oct 2022, 16:07 |
| /report/000121465922009391-kilcoyne-adrian-2022-07-27 | HUMANIGEN, INC | 27 Jul 2022 | 1 | $0 | 4 | Chief Medical Officer | 29 Jul 2022, 18:31 |
| /report/000121465922003919-kilcoyne-adrian-2022-03-08 | HUMANIGEN, INC | 08 Mar 2022 | 2 | +$31,610 | 4 | Chief Medical Officer | 14 Mar 2022, 16:37 |
| /report/000121465922000733-kilcoyne-adrian-2022-01-12 | HUMANIGEN, INC | 12 Jan 2022 | 1 | $0 | 4 | Chief Medical Officer | 14 Jan 2022, 16:05 |
| /report/000121465922000266-kilcoyne-adrian-2021-12-31 | HUMANIGEN, INC | 31 Dec 2021 | 1 | $0 | 4 | Chief Medical Officer | 04 Jan 2022, 17:20 |
| /report/000121465921012330-kilcoyne-adrian-2021-11-23 | HUMANIGEN, INC | 23 Nov 2021 | 1 | -$26,559 | 4 | Chief Medical Officer | 26 Nov 2021, 16:15 |
| /report/000121465921010213-kilcoyne-adrian-2021-09-30 | HUMANIGEN, INC | 30 Sep 2021 | 1 | $0 | 4 | Chief Medical Officer | 04 Oct 2021, 20:05 |